| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7505820 | Drug and Alcohol Dependence | 2014 | 36 Pages |
Abstract
Buprenorphine appears feasible and acceptable to prisoners who were not opioid-tolerant and can facilitate community treatment entry. However, concerns remain with in-prison treatment termination due to attempted diversion of medication.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Michael S. Gordon, Timothy W. Kinlock, Robert P. Schwartz, Terrence T. Fitzgerald, Kevin E. O'Grady, Frank J. Vocci,